A5091219923- Gestational Diabetes Research and Management
- Pregnancy and preeclampsia studies
- Birth, Development, and Health
- Pituitary Gland Disorders and Treatments
- Bariatric Surgery and Outcomes
- Prenatal Substance Exposure Effects
- Adrenal and Paraganglionic Tumors
- Diabetes Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Peroxisome Proliferator-Activated Receptors
- Diabetes Management and Research
- Gout, Hyperuricemia, Uric Acid
- Neurological and metabolic disorders
- Pancreatic function and diabetes
- Genetic Syndromes and Imprinting
- Biotin and Related Studies
- Heart Failure Treatment and Management
- Growth Hormone and Insulin-like Growth Factors
- Parathyroid Disorders and Treatments
- Kruppel-like factors research
- Magnesium in Health and Disease
- Neuroendocrine Tumor Research Advances
- Potassium and Related Disorders
- Blood disorders and treatments
- Thyroid and Parathyroid Surgery
Centro Hospitalar do Tâmega e Sousa
2020-2025
Hospital Padre Américo
2021-2024
Endocrinology Research Center
2021
A single prolactin sampling is recommended for the diagnosis of hyperprolactinemia. We aimed to study utility serial and determine best cut-offs associated with persistent hyperprolactinemia.Retrospective hyperprolactinemic patients [referral (rPRL)] that underwent samplings. Prolactin at 0 minutes (PRL0'), 20 30, 40 60 minutes. The lowest these last 2 was defined as nadir (nPRL). Persistent hyperprolactinemia nPRL above normal. excluded under dopamine receptor agonists. Receiver-operating...
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
Alpha-cell hyperplasia (ACH) is a rare pancreatic endocrine condition. Three types of ACH have been described: functional or nonglucagonoma hyperglucagonemic glucagonoma syndrome, reactive secondary to defective glucagon signaling, and non-functional. Few cases with concomitant neuroendocrine tumors (pNETs) reported its etiology remains poorly understood. A case report non-functional glucagon-producing NET herein presented.
Hypermagnesemia predicts mortality in chronic heart failure (HF); however, acute HF, magnesium does not seem to be outcome-associated. Diabetes mellitus (DM) frequently associates with altered status. We hypothesized that DM might influence the prognostic impact of HF.This is a retrospective cohort study hospitalized patients HF. Patients without data on admission serum were excluded. Follow-up: 1 year from hospital admission. Primary end point: all-cause mortality. divided according median...
Not required for Clinical Vignette.
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)